BioSpace News Archive

Company receives FDA 510(k) clearance for use of COHERE® interbody in XLIF® procedure as new clinical study further validates important benefits of Porous PEEK™ material technology

Conference Call and Webcast Scheduled for 5:00 p.m. Eastern Time

Revenue increases 79% to a record $5.3 million; achieves net income of $1.2 million

CONMED Corporation today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on January 7, 2019 to all shareholders of record as of December 14, 2018.

AURORA Phase III Trial in lupus nephritis completes enrollment ahead of schedule

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET

Ironwood Pharmaceuticals Inc. will present a corporate update at the 27th Annual Credit Suisse Healthcare Conference on Wednesday, November 14th, 2018 at 2:15 p.m.

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced financial results for the third quarter ended September 30, 2018 and provided updates on its clinical and preclinical programs. “

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) today announced that it has entered into a multi-year agreement with The Brink’s Company (NYSE: BCO) through its Brink’s Canada subsidiary to provide secure logistics and cash management services for Canopy Growth’s domestic and international cannabis operations.

Veracyte, Inc. announced today the publication of “real world” data showing that the Afirma® Genomic Sequencing Classifier (GSC) enables even more patients to avoid unnecessary surgery in thyroid cancer diagnosis compared to the company’s flagship, original Afirma Gene Expression Classifier (GEC). The findings are published online in Endocrine Practice, the journal of the American Association of Clinical Endocrinologists.